Haematology 2018

Conclusion

• DIBH implementation in lymphoma very succesful • Protocol in lung cancer patients ongoing

• Clear dosimetric benefit, even when using VMAT/IMRT

• Ressource investment: the ”sore points” are – PET scanning time – IGRT – And even then, they remain very manageable !